Fintech PR
Global investors wielding US$500 billion in capital eye new opportunities in world’s fastest growing economies at inaugural SuperBridge Summit Dubai
Leader in China’s AI movement; Asia’s ‘number one’ economist; and one of Mid East’s most powerful businesswomen among headliners confirmed for debut forum
DUBAI, UAE, Sept. 18, 2023 /PRNewswire/ — One of Japan’s largest investment firms with more than US$500 billion in assets under management (AUM) is spearheading an indomitable presence of Asian capital power at a UAE conference next month transforming a new global economy.
The inaugural SuperBridge Summit, taking place from 16-17 October 2023 at Dubai’s iconic Museum of the Future is a unique platform converging more than 500 investors, business, government, policy and cultural leaders from 20 countries to accelerate investment and co-creation opportunities in hitherto untapped and under-explored markets.
Channelled through future-focused outcomes, it will intensify collaborations in the world’s largest and rapidly expanding economies, including China, India, Indonesia, Vietnam, Brazil, UAE, Saudi Arabia, South Africa, and Nigeria, which, according to estimates, will collectively contribute over 45 percent of the world’s GDP by 2050.
The powerful two-day forum has confirmed a diverse international line-up of influential speakers seen for the first time in the Middle East, including Dr. Tuan Le Anh, Chief Investment Officer of Dragon Capital in Vietnam, and Takashi Maruyama, Chief Investment Officer, Asset Management One, Japan’s second largest asset management fund with half a trillion USD in AUM.
Joining more than 60 speakers from across the globe, Dr. Tuan and Mr. Maruyama will unlock the multifaceted investment value of cross-border capital allocation for the world’s estimated US$11.3 trillion worth of sovereign wealth funds.
Mr. Maruyama said cross-regional investments can play a beneficial role when building an investment portfolio, mitigating risk while offering the chance of superior returns. “However, they do expose investors to divergent regulatory frameworks, cultural nuances, and geopolitical dynamics,” he said. “Japan’s equity market has long been neglected by global investors despite the rally this year that captured wide attention.”
“I am looking forward to presenting the case of investing in Japan at SuperBridge Summit in Dubai, and doing a deep dive into the due diligence and strategic considerations that investors need to look at before embarking on the cross-regional journey.”
AI foundation models to advance research around cancer and other diseases
Reconciling future missions with today’s realities, SuperBridge Summit Dubai will connect the world’s new leaders, accelerating growth and prosperity via the most pertinent topics and issues under the overarching theme of Connectivity, Liveability, Sustainability, and Investments in a New Global Economy.
Dr. Hongjiang Zhang, Advisor to the Beijing Academy of AI in China, an award-winning computer scientist, holder of more than 150 patents, a Chinese AI guru, and author of numerous books, will sit on an executive panel unleashing AI for practical purposes in the real world.
Joined by prominent global AI leaders, Dr. Zhang’s session arrives as new research suggests generative AI, the type that powers LLM (large-language-model) technology, will generate $4.4 trillion in new value annually, unleashing a new wave of AI diffused productivity.
Dr. Zhang said the huge technological breakthrough in AI foundation models has catalysed a new turning point in the third wave of this cutting-edge tool: “As a fundamental platform, the AI foundation model will become the next generation of super entrance, systematically promoting industries into new paradigms, and making critical contributions to the efficiency revolution in various industries,” said Dr. Zhang, pointing to pharmaceuticals as a prime beneficiary.
“The Beijing Academy of Artificial Intelligence has made significant progress in using foundation models to reduce the design complexity of macromolecular drugs, and is expected to be applied in new treatment plans for diseases such as cancer.
“The foundation model will also greatly improve the production efficiency of traditional industries, such as finance, education, agriculture, manufacturing, and other fields, and will change the manufacturing process, production mode, and business model of these traditional industries.”
A pioneering initiative by KAOUN International, a subsidiary of Dubai World Trade Centre (DWTC), and the SuperBridge Council, the SuperBridge Summit Dubai is held in partnership with the 43rd edition of GITEX Global, the world’s largest and most influential tech event hosted in Dubai, attracting tech executives and investors from 170 countries.
Other headline speakers confirmed for the visionary programme include Dr. Jun Ma, Founder and President of China’s Institute of Finance and Sustainability, and Asia’s number one economist according to Institutional Investor; Noor Sweid, General Partner at Global Ventures, and ranked among the Forbes 100 most powerful Middle East businesswomen in 2023; and Lionel Zinsou, Founder and Managing Partner of SouthBridge Group, a financial advisory service company dedicated to Africa.
More information is available at www.superbridgedubai.com
Website:
http://superbridgedubai.com/
Press Registration:
http://event.superbridgedubai.com/MediaRegistration
On social media:
Facebook: https://www.facebook.com/superbridgesummit/
Instagram: https://www.instagram.com/superbridgesummit/
Twitter: https://twitter.com/superbridgedxb
LinkedIn: https://www.linkedin.com/company/superbridgesummit/about/
Hashtag:
#SuperBridgeDubai
About KAOUN International
KAOUN International is the independent events company and wholly owned subsidiary of Dubai World Trade Centre (DWTC) established to organize and manage events internationally. Derived from the Arabic word ‘universe‘, KAOUN International‘s mission is to ‘Create Limitless Connections‘ for the industries and markets in which it operates. Created to leverage the 40-year legacy of DWTC‘s events management business and drive future MICE sector opportunity in the MENASA region. KAOUN International delivers game-changing live experiences that build robust business connections, create opportunity, and stimulate economic growth, building on DWTC‘s extensive portfolio of business and consumer events spanning multiple sectors, including technology, food and hospitality, sustainability, broadcast and satellite, automotive, talent development and leisure marine.
About the SuperBridge Council
The SuperBridge Council was established to synergize and bring together a new non-political platform for global leaders from fast-growing economies. It bridges the old and the young, tradition and modernity, the north and the south, the east and the west, to inspire new strategies and forge sustainable solutions for the next generations to thrive. The inaugural edition of the show will take place from 16-17 October 2023, at the Museum of the Future in Dubai, UAE. More information: http://superbridgedubai.com/
Photo – https://mma.prnewswire.com/media/2213631/Takashi_Maruyama.jpg
Photo – https://mma.prnewswire.com/media/2213632/Zhang_Hong_Jiang.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/global-investors-wielding-us500-billion-in-capital-eye-new-opportunities-in-worlds-fastest-growing-economies-at-inaugural-superbridge-summit-dubai-301930704.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
https://news.cision.com/eqt/i/eqt-ab-group,c3285895 |
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News4 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News5 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News4 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News3 days ago
TWSE Becomes the First Exchange to Receive ISO 14068-1 Carbon Neutrality Certificate
-
Latest News2 days ago
KEYSTONE BANK HOLDS CUSTOMER FORUM, REITERATES COMMITMENT TO EXCELLENT SERVICE DELIVERY